Pierluigi Navarra

When innovation goes fast. The case of hemophilia.

Daniela Pilunni, Lorenzo Montrasio, Pierluigi Navarra, 2019, Current opinion in pharmacology.

Diffusion of complementary evolving pharmaceutical innovations: The case of Abacavir and its pharmacogenetic companion diagnostic in Italy

Ronnie Ramlogan, Dimitri Gagliardi, Pierluigi Navarra, 2018, Technological Forecasting and Social Change.

Exploiting Microglial Functions for the Treatment of Glioblastoma.

Pierluigi Navarra, L. Tentori, C. Dello Russo, 2017, Current cancer drug targets.

Evidence that corticotropin-releasing hormone inhibits cell growth of human breast cancer cells via the activation of CRH-R1 receptor subtype

Pierluigi Navarra, Giuseppe Tringali, L. Tentori, 2007, Molecular and Cellular Endocrinology.

n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway.

Pierluigi Navarra, Giuseppe Tringali, P. Palozza, 2004, Carcinogenesis.

Involvement of mTOR kinase in cytokine-dependent microglial activation and cell proliferation.

Pierluigi Navarra, Giuseppe Tringali, C. Dello Russo, 2009, Biochemical pharmacology.